JUN and cervical cancer: Crucially, inhibition of JNK1/2 using two chemically distinct inhibitors resulted in a ~70% and ~90% reduction, suggesting that JNK1/2 are the primary kinases required for c-Jun phosphorylation in HPV+ cervical cancer cells (Fig. 2B).